8.93
Schlusskurs vom Vortag:
$8.85
Offen:
$8.81
24-Stunden-Volumen:
817.34K
Relative Volume:
1.00
Marktkapitalisierung:
$528.83M
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$139.50M
KGV:
3.7655
EPS:
2.3715
Netto-Cashflow:
$205.80M
1W Leistung:
+1.02%
1M Leistung:
-1.54%
6M Leistung:
-37.07%
1J Leistung:
-25.58%
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
8.93 | 524.10M | 1.08B | 139.50M | 205.80M | 2.3715 |
|
ISRG
Intuitive Surgical Inc
|
452.58 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
155.32 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
74.63 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.88 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
224.93 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | Eingeleitet | BTIG Research | Neutral |
| 2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
Responsive Playbooks and the EMBC Inflection - news.stocktradersdaily.com
SG Americas Securities LLC Acquires Shares of 435,842 Embecta Corp. $EMBC - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Embecta Corp (JX7.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Embecta Corp Stock: A Focused Leader in Diabetes Care with Proven Products and Strategic Independenc - AD HOC NEWS
JPMorgan Chase & Co. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - MarketBeat
Embecta Corp. Stock Plummets to New 52-Week Low of $8.47 - Markets Mojo
Market Rankings: Why is Embecta Corp stock going upShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
Mills & Reeve advises Owen Mumford on £150m sale to embecta Corp in New Jersey - Business Weekly
Embecta agrees to acquire Owen Mumford - MSN
Embecta Corp. Stock Plummets to New 52-Week Low of $8.68 - Markets Mojo
Vanguard reorganizes reporting; EMBC ownership listed as 0 (EMBC) - Stock Titan
Embecta (NASDAQ:EMBC) Sets New 12-Month LowTime to Sell? - MarketBeat
Understanding the Setup: (EMBC) and Scalable Risk - news.stocktradersdaily.com
“Landmark moment” for medical device manufacturer with sale to Nasdaq-listed groupMills & Reeve advised - Insider Media Ltd
Embecta Plans Acquisition of Owen Mumford to Broaden Drug-Delivery Offerings - Bitget
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio - Zacks Investment Research
Embecta to buy Owen Mumford for up to £150M - MSN
Performance Recap: Will Embecta Corp stock go up in YEAR2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Embecta: £150 Million Acquisition Of Owen Mumford To Expand Drug Delivery Platform Capabilities - Pulse 2.0
Embecta rallies after UK firm deal worth $200 million - MSN
Aug Gainers: What is the PEG ratio of Embecta Corp2026 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Embecta to Acquire Owen Mumford for Up to £150 Million, Expanding Drug-Delivery Device Portfolio and Global Medical Supplies Presence 123 - Minichart
Embecta to Acquire Owen Mumford in £150M Deal, Expanding Drug Delivery and Chronic Care Portfolio - Pharmacy Times
Embecta to Acquire Owen Mumford, Expanding Drug-Delivery Portfolio - tipranks.com
Embecta (NASDAQ: EMBC) to acquire Owen Mumford in up to £150m deal - Stock Titan
Embecta to acquire Owen Mumford for up to £150 million By Investing.com - Investing.com India
Embecta Corp. agreed to acquire Owen Mumford Holdings Limited from Mark Owen, Adam Mumford, Ellen Owen, Kim Priddis,Nancy Millington and others for approximately £150 million. - MarketScreener
EmbectaAn Interesting Deal At An Interesting Time (NASDAQ:EMBC) - Seeking Alpha
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M - drugdeliverybusiness.com
Embecta to buy Owen Mumford for up to $201M - MedTech Dive
Embecta to acquire UK medical device maker Owen Mumford for $200M - NJBIZ
Embecta (NASDAQ:EMBC) Trading 4.5% HigherTime to Buy? - MarketBeat
Embecta to Acquire Owen Mumford for up to $199.4M - Medical Product Outsourcing
Embecta acquires Owen Mumford for £150M - BioWorld MedTech
Embecta’s $133M Acquisition of Owen Mumford Marks a Turning Point - Medical Device and Diagnostic industry
Embecta Rallies After UK Firm Deal Worth $200 Million - Benzinga
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal By Investing.com - Investing.com Australia
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal - Investing.com UK
Embecta to acquire Owen Mumford - Drug Store News
Embecta Corp. Stock Plummets to New 52-Week Low of $8.74 - Markets Mojo
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):